Video:

There are several techniques and materials available for implant site development. The choice may depend on a number of factors including size of the defect, osseous morphology, costs and surgeon or patient preferences. Autogenous bone has long been considered the gold standard of graft materials. The trend today is to reduce patient morbidity but still provide predictable outcomes. This lecture will discuss the use of autogenous bone versus using bioactive modifiers such as platelet concentrates, rhPDGF and rhBMP-2 as replacement for the need to harvest bone.